Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GPN00884 Eye Drops for Delaying Myopia Progression in Children (Phase IIa)
ChiCTR2500109856Phase 2Not yet recruiting
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Sep 2025
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GPN00884 in myopia (5 arms), sponsored by Zhongshan Ophthalmic Center. Primary endpoint: Spherical equivalent refraction (SER) change at 48 weeks. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
GPN00884
03
Conditions
myopia
Beyond the preview
Go deeper on ChiCTR2500109856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109856.